Eplerenone
Inspra (eplerenone) is a small molecule pharmaceutical. Eplerenone was first approved as Inspra on 2002-09-27. It is used to treat hypertension and systolic heart failure in the USA. The pharmaceutical is active against mineralocorticoid receptor.
| Trade Name | Inspra |
|---|---|
| Common Name | Eplerenone |
| Indication | hypertension, systolic heart failure |
| Drug Class | Aldosterone antagonists (spironolactone type) |
